CIK 0001783328
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
TScan Therapeutics, Inc.
Sign in to watch- Ticker
- TCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 825282075
- Phone
- +1 857-399-9500
- Business address
- 830 WINTER STREET, WALTHAM, MA, 02451
- 4 Open-market buy Chief Executive Officer bought 11,000 shares at $8.73 ($96,066)
- 4 Open-market buy Chief Business Officer bought 2,500 shares at $9.08 ($22,708)
- 4 Open-market buy 10% owner bought 133,333 shares at $15.00 ($1,999,995)
- 4 Open-market buy Director bought 1,425,000 shares at $15.00 ($21,375,000)
- 4 Conversion Director acquired 33,259 shares (conversion)
- 4 Open-market buy Chief Financial Officer bought 1,000 shares at $15.00 ($15,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 6 of 6 · 119 filings